Godwin Mary E.
SEC insider (Form 3/4/5 filer). CIK 0001439716. Senior VP, Operations at Nautilus Biotechnology, Inc. (NAUT). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2024. Located in SEATTLE, WA.
Companies Godwin Mary E. has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Officer, Senior VP, Operations
Godwin Mary E.
CIK: 0001439716
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 23, 2024NAUT
Nautilus Biotechnology, Inc.
ExerciseDirect47K shares at avg. $0.46$22K - Sep 23, 2024NAUT
Nautilus Biotechnology, Inc.
SaleDirect47K shares at avg. $2.87$135K - Sep 17, 2024NAUT
Nautilus Biotechnology, Inc.
ExerciseDirect35K shares at avg. $0.46$16K - Sep 17, 2024NAUT
Nautilus Biotechnology, Inc.
SaleDirect35K shares at avg. $2.85$100K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | Exercise | 47,031 | $0.46 | $21,634 | Direct |
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | Sale | 47,031 | $2.87 | $134,744 | Direct |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | Exercise | 35,000 | $0.46 | $16,100 | Direct |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | Sale | 35,000 | $2.85 | $99,869 | Direct |
1-4 of 4 transactions